What Color Is Plasma and What Do Abnormal Colors Mean?

Healthy human blood plasma is a translucent, straw-yellow to light amber fluid, and that color comes primarily from two pigments naturally circulating in the bloodstream: bilirubin, a byproduct of red blood cell breakdown, and carotenoids absorbed from food.¹ When plasma shifts away from that baseline yellow, whether it turns milky white, deep orange, pink, green, or brown, it tells a surprisingly specific story about what is happening inside the body or, sometimes, what went wrong with the blood sample after it was drawn.

Why Normal Plasma Looks Yellow

Plasma makes up roughly 55 percent of total blood volume. It is mostly water, with dissolved proteins, electrolytes, hormones, and waste products suspended in it. Once you spin blood in a centrifuge and separate out the red cells, white cells, and platelets, you are left with this pale yellow liquid. The yellow hue is faint and can look almost clear in some people. It deepens slightly with higher concentrations of bilirubin or carotenoids, both of which are normal constituents of blood. Bilirubin is continuously produced as the body recycles old red blood cells, while carotenoids are plant-derived pigments that enter the bloodstream through diet, particularly from vegetables and fruits rich in beta-carotene.

Because these pigment levels vary from person to person and day to day, “normal” plasma color actually sits on a spectrum from nearly colorless to a moderate amber. In blood banks, technicians routinely look at the color and clarity of separated plasma to decide whether a unit is suitable for transfusion. A clear, amber-toned sample without any turbidity is considered the healthy baseline.²

Milky White or Cloudy Plasma (Lipemia)

One of the most visually striking changes is lipemia, where plasma turns milky white or opaque, resembling diluted milk. This happens when triglyceride levels in the blood become very high. Specifically, plasma begins to look turbid once triglycerides exceed roughly 1,000 mg/dL, a threshold at which chylomicrons and very-low-density lipoproteins accumulate enough to scatter light.³ At more moderate elevations, plasma just looks slightly hazy. Above that threshold, it can become fully opaque.

A common and benign cause of lipemic plasma is simply eating a fatty meal within a few hours before a blood draw. Fats from the meal circulate as chylomicrons, and they temporarily cloud the plasma. This is one reason fasting blood draws are standard for lipid panels. But persistent lipemia in a fasting sample points to something else: uncontrolled diabetes, heavy alcohol use, hypothyroidism, or genetic lipid disorders. The case report describing alcohol-induced acute hypertriglyceridaemia, for instance, documented a patient whose plasma appeared frankly milky white after binge drinking triggered a massive surge in triglycerides.³

Lipemia matters beyond appearances because it interferes with lab testing. The fat particles scatter light and absorb wavelengths that analyzers use to measure other substances, throwing off results for a wide range of tests. Research has shown that lipemia significantly distorts measurements of calcium, magnesium, phosphorus, total protein, iron, and several other analytes, and that neither simple dilution nor mathematical correction fully compensates for the interference. Ultracentrifugation, which physically removes the lipid layer, remains the most reliable way to get accurate results from a lipemic sample.⁴

Pink or Red Plasma (Hemolysis)

When plasma turns pink, red, or even cherry-colored, it usually signals hemolysis: red blood cells have ruptured and released their hemoglobin into the surrounding fluid. In the lab, hemolysis is the most common reason a blood sample gets flagged or rejected. The shade correlates roughly with the amount of free hemoglobin. A faint pink suggests mild hemolysis, while a deep red means extensive cell damage.

Most hemolysis in practice is caused by the blood draw itself rather than something happening inside the patient. Drawing blood through a needle that is too small, applying too much suction on the syringe, shaking the tube vigorously, or exposing the sample to extreme temperatures can all pop red blood cells. Pneumatic tube systems that shuttle specimens across a hospital are another frequent culprit. These are pre-analytical problems, and they can make it look like a patient has abnormal lab values when the patient is actually fine.

True in-vivo hemolysis, where red blood cells break apart inside the body, is a different matter. It occurs in conditions like autoimmune hemolytic anemia, certain infections such as malaria, transfusion reactions, mechanical heart valves shearing cells, and some toxin exposures. When a clinician sees hemolyzed plasma and the draw technique was clean, it prompts investigation into these possibilities.

Hemolysis is a problem for lab testing for the same basic reason lipemia is: the free hemoglobin absorbs light at specific wavelengths and throws off photometric measurements. Potassium results are especially vulnerable, because red blood cells contain much more potassium than the surrounding plasma. When those cells burst, potassium floods into the sample, and the reported level shoots up artificially. A lab tech who sees pink plasma knows to question the potassium result before anyone uses it to make a treatment decision.

Deep Yellow to Orange Plasma (Icterus)

While a mild yellow tint is perfectly normal, plasma that has turned deep golden, orange, or almost brownish-yellow is described as icteric. The word comes from the same root as jaundice, and the cause is the same: elevated bilirubin. When bilirubin in the blood climbs above its normal range, the change is visible both in the patient, whose skin and eyes may yellow, and in their separated plasma.

Bilirubin rises for three general reasons. The body may be producing too much of it, as happens with hemolytic anemias or large bruises being reabsorbed. The liver may be struggling to process bilirubin at a normal rate, as in hepatitis, cirrhosis, or drug-induced liver injury. Or the bile ducts that carry bilirubin out of the liver may be blocked, as in gallstone obstruction or pancreatic tumors. The shade of the icteric plasma does not reliably distinguish these causes, but the degree of discoloration correlates loosely with the bilirubin level.

From a lab standpoint, icteric plasma creates interference with certain colorimetric assays. Some tests measure substances at wavelengths where bilirubin also absorbs light, leading to over- or under-estimation. Modern analyzers flag icteric samples automatically, but in smaller labs, catching icterus still depends on a trained eye looking at the sample before running it.

Green Plasma

Green plasma is rare and tends to alarm whoever encounters it, but it is usually benign. The most common cause is elevated ceruloplasmin, a copper-carrying protein that has a blue-green color. Ceruloplasmin rises in response to high estrogen levels, which is why green plasma shows up most often in people taking oral contraceptive pills or during pregnancy.¹ The combination of the blue-green ceruloplasmin layered on top of the normal yellow bilirubin tint produces a distinctly greenish hue.

A more unusual cause described in the literature is chronic tobacco chewing. One case report documented green plasma in a healthy male blood donor who was a habitual tobacco chewer, an association the authors flagged as uncommon.¹ Another possible cause is sulfhemoglobinemia, a condition in which hemoglobin binds irreversibly with sulfur, turning the blood a dark greenish-brown. Sulfhemoglobinemia has been linked to overuse of certain medications, including phenazopyridine, a urinary pain reliever available over the counter in some countries.

For blood banks, green plasma units are typically flagged during visual inspection and may be deferred from transfusion while the cause is investigated. In most cases, the donor turns out to be on hormonal contraception or has some other explainable reason, and the plasma itself is safe. Still, the visual check acts as an early-warning system that something unusual is circulating in the donor’s blood.

Medications That Change Plasma Color

The range of drugs that can alter plasma color is broader than most people realize. At least eleven substances and conditions have been documented to discolor plasma into shades ranging from orange to red to brown, including some widely used therapies. Additional substances can produce blue, green, or white discoloration.⁵

This is clinically important because drug-induced discoloration can mimic hemolysis. If a patient is on a medication that turns their plasma red or brown, a lab tech or clinician looking at the sample might assume red blood cells have ruptured and launch an unnecessary workup. Knowing which drugs cause which colors prevents that kind of costly misdirection. A few examples that come up in practice:

Hydroxocobalamin: a form of vitamin B12 used as an antidote for cyanide poisoning. It turns plasma a deep red that looks strikingly like hemolysis.
Eltrombopag: a medication used to boost platelet counts. It gives plasma an orange to brown tint.
Iron dextran: an intravenous iron preparation. It can turn serum dark brown.
Propofol: the anesthetic sometimes produces a greenish tinge in plasma, likely related to its lipid emulsion vehicle.

The key practical point is that unusual plasma color in a hospitalized patient should prompt a medication review before assuming the color reflects a disease process. A pharmacist or lab specialist who recognizes the drug-color pattern can save the patient from unnecessary testing.

How Labs Detect and Manage Abnormal Plasma Colors

The three interferences that labs track most closely are hemolysis, icterus, and lipemia, collectively abbreviated as HIL. Modern automated chemistry analyzers measure HIL indices by shining light through the sample at multiple wavelengths and detecting how much light is absorbed or scattered. The hemoglobin from hemolysis, the bilirubin causing icterus, and the triglycerides behind lipemia each have characteristic absorption or scattering profiles. The analyzer uses these to assign a semi-quantitative grade, often on a scale from 0 to 4+, indicating how much of each interferent is present.⁶ Some platforms report the values quantitatively rather than in graded categories, giving exact concentrations of the interfering substances.⁷

Before automation made this routine, detection relied entirely on visual inspection. A technician would hold the separated sample up to a light and judge its color and clarity. This method is still used in smaller labs and blood banks, but it has well-documented limitations. Visual assessment suffers from significant person-to-person variation: two technicians looking at the same tube may classify it differently. For hemolyzed samples, subtle pink tints are easy to miss, especially when lipemia is also present and clouding the view. For lipemic samples, the human eye struggles to distinguish between moderate and severe turbidity once the plasma becomes fully opaque.⁸ Studies have found that as many as half of hemolyzed samples classified visually are rejected unnecessarily, meaning the classification was wrong.²

When a sample is flagged as lipemic and the test results are needed urgently, labs have several tools. The gold standard is ultracentrifugation, which spins the sample at extremely high forces to physically separate and remove the lipid layer. However, ultracentrifuges are expensive and not available in every lab.⁹ Alternatives include high-speed centrifugation at lower forces, which approaches ultracentrifuge performance for most analytes, and commercial products such as LipoClear, a polymer reagent that binds lipids so they can be pelleted out with standard centrifugation.¹⁰ Each of these methods has trade-offs in cost, turnaround time, and which analytes remain accurate after treatment.

What Plasma Color Means in Blood Donation

When you donate blood, the collected unit is processed and separated into components: red cells, platelets, and plasma. Each component goes through quality checks before it can be given to a patient. For plasma, one of the first quality gates is its appearance. A unit that looks milky, red, brown, or green gets pulled out of the normal processing line for further evaluation.

Lipemic donations are the most common visual abnormality in blood banks, and they are almost always linked to the donor having eaten a fatty meal too close to the donation time. Blood collection centers often ask donors to avoid high-fat foods before an appointment precisely for this reason. A milky plasma unit is usually discarded or diverted to non-clinical uses because the fat content can cause adverse reactions in transfusion recipients and interferes with lab testing of the unit itself.

Hemolyzed units also get flagged. If the plasma layer has a visible pink or red hue, it may mean the collection or processing damaged the red cells. Transfusing hemolyzed blood products can cause kidney problems and other complications in the recipient, so these units are typically discarded. Green units, as discussed earlier, are usually benign but get deferred until the cause is confirmed. The visual inspection step, for all its limitations compared to automated analysis, remains a standard gatekeeper in transfusion medicine.

Blue-Green Blood in Other Animals

If you think green human plasma is unusual, consider that some marine fish have blue-green blood plasma as a normal feature. The color comes from biliverdin, a green pigment that is actually the chemical precursor to bilirubin. In humans, biliverdin gets quickly converted to bilirubin by the liver, so we rarely see it in circulation. But in certain fish species, biliverdin remains in the blood at high concentrations, bound to plasma proteins, giving the blood a vivid blue-green color.¹¹

This biliverdin pigmentation is not confined to fish. The same pigment shows up in the wings of butterflies and moths, the shells of bird eggs, and the placenta of dogs. In frogs, biliverdin has been found in both blood serum and eggs. And in humans, elevated blood biliverdin does occur, but only pathologically, in certain liver diseases that impair the normal conversion to bilirubin.¹¹ The fact that so many unrelated species use the same pigment in entirely different tissues suggests biliverdin has biological roles beyond waste disposal, possibly including antioxidant protection, though the evolutionary picture is still being worked out.

When You Should Actually Worry

If you are a patient and someone mentions your plasma looked unusual, context matters enormously. A lipemic sample from a non-fasting blood draw means nothing about your health. A hemolyzed sample collected through a difficult IV line just means the draw was rough on your blood cells. These are pre-analytical problems, not diagnoses.

The situations that do warrant follow-up are the ones where the abnormal color reflects something happening inside you rather than in the collection tube. Persistently icteric plasma on a fasting sample suggests your liver or bile ducts need investigation. Recurrent hemolysis in cleanly drawn samples points toward a hemolytic process. Lipemic plasma in someone who fasted for twelve hours before the draw raises questions about metabolic disorders or uncontrolled diabetes. And while green plasma is almost always benign, a deep brownish-green in someone not on hormonal medication or with known sulfhemoglobinemia triggers warrants further evaluation.

For donors, the main actionable takeaway is mundane: eat a low-fat meal before donating, stay hydrated, and mention any medications to the collection staff. The majority of plasma units that get rejected are rejected for preventable reasons. And for the lab professionals reading this, the evidence increasingly favors automated HIL detection over visual inspection whenever available, particularly for hemolysis, where visual misclassification rates remain stubbornly high even among experienced staff.

1
Europe PMC / Asian Journal of Transfusion Science. Greenish discoloration of plasma: Is it really a matter of concern?
2
MDPI. Visual Assessment of Blood Plasma versus Optical Transmittance and Refractive Index Measurements for Quantifying Lipemia
3
Europe PMC / BMJ Case Reports. Lipaemic blood: alcohol-induced acute hypertriglyceridaemia
4
PubMed Central. Lipemia Interferences in Biochemical Tests, Investigating the Efficacy of Different Removal Methods in comparison with Ultracentrifugation as the Gold Standard
5
Oxford Academic (American Journal of Clinical Pathology). Drugs and Conditions That May Mimic Hemolysis
6
PubMed Central. Optimization of hemolysis, icterus and lipemia interference thresholds for 35 clinical chemistry assays
7
Laboratory Medicine Online. Hemolysis, Icterus, and Lipemia: Evaluation of Interference in Laboratory Results Using Automated Chemistry Analyzers
8
SAGE Journals (Academic Pathology). Educational Case: Hemolysis and Lipemia Interference With Laboratory Testing
9
Biochemia Medica. Lipemia: causes, interference mechanisms, detection and management
10
PubMed Central. Removing Lipemia in Serum/Plasma Samples: A Multicenter Study
11
PubMed Central. The blue-green blood plasma of marine fish